Post Profile






Common prostate cancer treatment linked to later dementia, researcher says

Men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with, research shows.
read more

share

Related Posts


Is androgen deprivation therapy for prostate cancer associated with dementia?

Diseases & Conditions / Cancer : EurekAlert: Cancer

(The JAMA Network Journals) Androgen deprivation therapy is a mainstay of prostate cancer treatment. ADT has shown survival benefit in some patients but it also has been associated with some adverse health effects and a possible lin...

Prostate Cancer Treatment Can Raise Dementia Risk

Health : Well

Reducing testosterone levels with androgen deprivation therapy, or A.D.T., more than doubles the risk of dementia.

Medical News Today: Hormone therapy for prostate cancer may raise dementia risk

Health : Medical News Today

Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.

Common Prostate Cancer Treatment Tied to Dementia

Health : Newswise Medical News

Androgen Deprivation Therapy, a common hormone therapy to treat prostate cancer, may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported.

Common prostate cancer treatment linked to later dementia, Stanford researcher says

Diseases & Conditions / Cancer : EurekAlert: Cancer

(Stanford University Medical Center) A new retrospective study of the health records of prostate cancer patients supports an association between androgen deprivation therapy and future risk of dementia.

Comments


Copyright © 2016 Regator, LLC